,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1603027,178033,Comparative Toxicogenomics Database (CTD),Russian VX,C451779,"S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate",https://ctdbase.org/detail.go?type=chem&acc=C451779,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606,Homo sapiens (human),"N,N'-monomethylenebis(pyridiniumaldoxime) affects the reaction [S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate results in decreased activity of ACHE protein]|hlo 7 affects the reaction [S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate results in decreased activity of ACHE protein]|asoxime chloride affects the reaction [S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate results in decreased activity of ACHE protein]",,,PMID:25451328,https://www.ncbi.nlm.nih.gov/pubmed/25451328,25451328,,
1,1603028,178033,Comparative Toxicogenomics Database (CTD),Russian VX,C451779,"S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate",https://ctdbase.org/detail.go?type=chem&acc=C451779,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606,Homo sapiens (human),"Asoxime chloride inhibits the reaction [S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate results in decreased activity of ACHE protein]",,,PMID:18555982|PMID:20433814,https://www.ncbi.nlm.nih.gov/pubmed/18555982|https://www.ncbi.nlm.nih.gov/pubmed/20433814,18555982|20433814,,
2,1604231,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,9582,APOBEC3B,https://ctdbase.org/detail.go?type=gene&acc=9582,,,9582.0,APOBEC3B,9606,Homo sapiens (human),Dimethylarsinous acid results in increased expression of APOBEC3B mRNA,,,PMID:23876855,https://www.ncbi.nlm.nih.gov/pubmed/23876855,23876855,,
3,1604232,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090,Mus musculus (house mouse),APOE protein affects the susceptibility to dimethylarsinous acid,,,PMID:28728140,https://www.ncbi.nlm.nih.gov/pubmed/28728140,28728140,,
4,1604233,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,54622,ARL15,https://ctdbase.org/detail.go?type=gene&acc=54622,,,54622.0,ARL15,9606,Homo sapiens (human),Dimethylarsinous acid results in decreased expression of ARL15 mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
5,1604234,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,10123,ARL4C,https://ctdbase.org/detail.go?type=gene&acc=10123,,,10123.0,ARL4C,9606,Homo sapiens (human),Dimethylarsinous acid results in decreased expression of ARL4C mRNA,,,PMID:23487506,https://www.ncbi.nlm.nih.gov/pubmed/23487506,23487506,,
6,1604235,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,9606,Homo sapiens (human),[AS3MT gene SNP affects the susceptibility to arsenic] which affects the abundance of dimethylarsinous acid,,,PMID:29859237,https://www.ncbi.nlm.nih.gov/pubmed/29859237,29859237,,
7,1604411,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,9606,Homo sapiens (human),[AS3MT protein binds to and results in increased methylation of arsenite] which results in increased chemical synthesis of dimethylarsinous acid,,,PMID:25349987,https://www.ncbi.nlm.nih.gov/pubmed/25349987,25349987,,
8,1601258,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57519,STARD9,https://ctdbase.org/detail.go?type=gene&acc=57519,,,57519.0,STARD9,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of STARD9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
9,1601259,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of STAT1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
10,1601260,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of STAT1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
11,1601261,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of STAT1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
12,1601262,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of STAT3 mRNA,,,PMID:21641981|PMID:28943387,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/28943387,21641981|28943387,,
13,1601263,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of STAT5A mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
14,1601264,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of STAT5B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
15,1601745,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10963,STIP1,https://ctdbase.org/detail.go?type=gene&acc=10963,,,10963.0,STIP1,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of STIP1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
16,1601746,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6794,STK11,https://ctdbase.org/detail.go?type=gene&acc=6794,,,6794.0,STK11,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of STK11 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
17,1601747,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,114790,STK11IP,https://ctdbase.org/detail.go?type=gene&acc=114790,,,114790.0,STK11IP,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of STK11IP intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
18,1601748,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9263,STK17A,https://ctdbase.org/detail.go?type=gene&acc=9263,,,9263.0,STK17A,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of STK17A protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
19,1601749,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9263,STK17A,https://ctdbase.org/detail.go?type=gene&acc=9263,,,9263.0,STK17A,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of STK17A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
20,1601750,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9263,STK17A,https://ctdbase.org/detail.go?type=gene&acc=9263,,,9263.0,STK17A,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of STK17A mRNA,,,PMID:21641981|PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21641981|22100608|27153756,,
21,1601751,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9262,STK17B,https://ctdbase.org/detail.go?type=gene&acc=9262,,,9262.0,STK17B,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of STK17B intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
22,1601858,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9262,STK17B,https://ctdbase.org/detail.go?type=gene&acc=9262,,,9262.0,STK17B,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of STK17B mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
23,1603020,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8801,SUCLG2,https://ctdbase.org/detail.go?type=gene&acc=8801,,,8801.0,SUCLG2,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of SUCLG2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
24,1603021,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,101927111,SUCLG2-DT,https://ctdbase.org/detail.go?type=gene&acc=101927111,,,101927111.0,SUCLG2-DT,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SUCLG2-DT intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
25,1603022,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,56670,SUCNR1,https://ctdbase.org/detail.go?type=gene&acc=56670,,,56670.0,SUCNR1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of SUCNR1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
26,1603023,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51430,SUCO,https://ctdbase.org/detail.go?type=gene&acc=51430,,,51430.0,SUCO,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SUCO gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
27,1603024,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64426,SUDS3,https://ctdbase.org/detail.go?type=gene&acc=64426,,,64426.0,SUDS3,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SUDS3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
28,1603025,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64426,SUDS3,https://ctdbase.org/detail.go?type=gene&acc=64426,,,64426.0,SUDS3,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of SUDS3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
29,1603026,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79783,SUGCT,https://ctdbase.org/detail.go?type=gene&acc=79783,,,79783.0,SUGCT,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of SUGCT mRNA,,,PMID:22100608|PMID:32234424|PMID:35690182,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/35690182,22100608|32234424|35690182,,
30,1604329,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6850,SYK,https://ctdbase.org/detail.go?type=gene&acc=6850,,,6850.0,SYK,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SYK gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
31,1604330,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8189,SYMPK,https://ctdbase.org/detail.go?type=gene&acc=8189,,,8189.0,SYMPK,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of SYMPK mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
32,1604331,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SYN1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
33,1604332,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6854,SYN2,https://ctdbase.org/detail.go?type=gene&acc=6854,,,6854.0,SYN2,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SYN2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
34,1604333,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6854,SYN2,https://ctdbase.org/detail.go?type=gene&acc=6854,,,6854.0,SYN2,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of SYN2 mRNA,,,PMID:23630614,https://www.ncbi.nlm.nih.gov/pubmed/23630614,23630614,,
35,1604334,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8224,SYN3,https://ctdbase.org/detail.go?type=gene&acc=8224,,,8224.0,SYN3,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SYN3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
36,1601147,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,394,ARHGAP5,https://ctdbase.org/detail.go?type=gene&acc=394,,,394.0,ARHGAP5,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of ARHGAP5 mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
37,1601148,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,396,ARHGDIA,https://ctdbase.org/detail.go?type=gene&acc=396,,,396.0,ARHGDIA,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ARHGDIA protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
38,1601149,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,392509,ARL13A,https://ctdbase.org/detail.go?type=gene&acc=392509,,,392509.0,ARL13A,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ARL13A mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
39,1601150,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,379,ARL4D,https://ctdbase.org/detail.go?type=gene&acc=379,,,379.0,ARL4D,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ARL4D mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
40,1601151,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,568579,ASB15B,https://ctdbase.org/detail.go?type=gene&acc=568579,,,568579.0,asb15b,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ASB15B mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
41,1601152,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,471,ATIC,https://ctdbase.org/detail.go?type=gene&acc=471,,,471.0,ATIC,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ATIC protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
42,1601153,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,220202,ATOH7,https://ctdbase.org/detail.go?type=gene&acc=220202,,,220202.0,ATOH7,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ATOH7 mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
43,1601154,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,64611,ATP1A3B,https://ctdbase.org/detail.go?type=gene&acc=64611,,,64611.0,atp1a3b,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ATP1A3B protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
44,1601155,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,487,ATP2A1,https://ctdbase.org/detail.go?type=gene&acc=487,,,487.0,ATP2A1,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of ATP2A1 protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
45,1602440,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,415152,GYG1B,https://ctdbase.org/detail.go?type=gene&acc=415152,,,415152.0,gyg1b,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of GYG1B protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
46,1602441,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,100529164,HCE,https://ctdbase.org/detail.go?type=gene&acc=100529164,,,100529164.0,hce,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of HCE mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
47,1602442,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,3074,HEXB,https://ctdbase.org/detail.go?type=gene&acc=3074,,,3074.0,HEXB,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of HEXB protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
48,1602443,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,3174,HNF4G,https://ctdbase.org/detail.go?type=gene&acc=3174,,,3174.0,HNF4G,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of HNF4G mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
49,1602444,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,327588,HPXA,https://ctdbase.org/detail.go?type=gene&acc=327588,,,327588.0,hpxa,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of HPXA mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
50,1602445,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,100151174,HS2ST1B,https://ctdbase.org/detail.go?type=gene&acc=100151174,,,100151174.0,hs2st1b,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of HS2ST1B mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
51,1602446,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,3298,HSF2,https://ctdbase.org/detail.go?type=gene&acc=3298,,,3298.0,HSF2,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of HSF2 mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
52,1602447,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,335865,HSPA4A,https://ctdbase.org/detail.go?type=gene&acc=335865,,,335865.0,hspa4a,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of HSPA4A mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
53,1602448,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,3418,IDH2,https://ctdbase.org/detail.go?type=gene&acc=3418,,,3418.0,IDH2,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of IDH2 protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
54,1602899,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,100134855,MST1RB,https://ctdbase.org/detail.go?type=gene&acc=100134855,,,100134855.0,mst1rb,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of MST1RB mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
55,1602900,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,4695,NDUFA2,https://ctdbase.org/detail.go?type=gene&acc=4695,,,4695.0,NDUFA2,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of NDUFA2 mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
56,1602901,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,4725,NDUFS5,https://ctdbase.org/detail.go?type=gene&acc=4725,,,4725.0,NDUFS5,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of NDUFS5 mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
57,1602902,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,724016,NPAS4A,https://ctdbase.org/detail.go?type=gene&acc=724016,,,724016.0,npas4a,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of NPAS4A mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
58,1602903,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,4868,NPHS1,https://ctdbase.org/detail.go?type=gene&acc=4868,,,4868.0,NPHS1,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of NPHS1 mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
59,1602904,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,563150,NR1D4A,https://ctdbase.org/detail.go?type=gene&acc=563150,,,563150.0,nr1d4a,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of NR1D4A mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
60,1602905,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,574006,OMPA,https://ctdbase.org/detail.go?type=gene&acc=574006,,,574006.0,ompa,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of OMPA mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
61,1602906,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,30582,OPN1SW1,https://ctdbase.org/detail.go?type=gene&acc=30582,,,30582.0,opn1sw1,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of OPN1SW1 mRNA",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
62,1602907,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,5034,P4HB,https://ctdbase.org/detail.go?type=gene&acc=5034,,,5034.0,P4HB,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in decreased expression of P4HB protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
63,1602908,296646,Comparative Toxicogenomics Database (CTD),"1,2,5,6-Tetrabromocyclooctane",C540596,"1,2,5,6-tetrabromocyclooctane",https://ctdbase.org/detail.go?type=chem&acc=C540596,606498,PABPC1A,https://ctdbase.org/detail.go?type=gene&acc=606498,,,606498.0,pabpc1a,8090,Oryzias latipes (Japanese medaka),"1,2,5,6-tetrabromocyclooctane results in increased expression of PABPC1A protein",,,PMID:27322799,https://www.ncbi.nlm.nih.gov/pubmed/27322799,27322799,,
64,1600384,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,9606,Homo sapiens (human),Bortezomib results in increased expression of XBP1 protein alternative form|[ricolinostat co-treated with bortezomib] results in increased expression of XBP1 protein alternative form,,,PMID:22262760,https://www.ncbi.nlm.nih.gov/pubmed/22262760,22262760,,
65,1600385,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,6375,XCL1,https://ctdbase.org/detail.go?type=gene&acc=6375,,,6375.0,XCL1,9606,Homo sapiens (human),Bortezomib results in decreased expression of XCL1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
66,1600386,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606,Homo sapiens (human),Boc-D-FMK inhibits the reaction [[bortezomib co-treated with butyrates] results in decreased expression of XIAP protein]|acetylcysteine inhibits the reaction [[bortezomib co-treated with butyrates] results in decreased expression of XIAP protein]|[bortezomib co-treated with vorinostat] results in decreased expression of XIAP protein|[bortezomib co-treated with butyrates] results in decreased expression of XIAP protein|[[bortezomib co-treated with vorinostat] results in increased abundance of reactive oxygen species] which results in decreased expression of XIAP protein|acetylcysteine inhibits the reaction [[bortezomib co-treated with vorinostat] results in decreased expression of XIAP protein]|boc-D-FMK inhibits the reaction [[bortezomib co-treated with vorinostat] results in decreased expression of XIAP protein]|[[bortezomib co-treated with butyrates] results in increased abundance of reactive oxygen species] which results in decreased expression of XIAP protein,,,PMID:15173093,https://www.ncbi.nlm.nih.gov/pubmed/15173093,15173093,,
67,1600387,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606,Homo sapiens (human),Bortezomib affects the expression of XIAP protein,,,PMID:17326159,https://www.ncbi.nlm.nih.gov/pubmed/17326159,17326159,,
68,1600388,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606,Homo sapiens (human),Bortezomib results in increased cleavage of XIAP protein|tnfsf10 protein promotes the reaction [bortezomib results in increased cleavage of XIAP protein]|bortezomib promotes the reaction [TNFSF10 protein results in increased cleavage of XIAP protein],,,PMID:19100720,https://www.ncbi.nlm.nih.gov/pubmed/19100720,19100720,,
69,1600389,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606,Homo sapiens (human),Bortezomib results in decreased expression of XIAP protein,,,PMID:15543232|PMID:17626072|PMID:18850583|PMID:19636294,https://www.ncbi.nlm.nih.gov/pubmed/15543232|https://www.ncbi.nlm.nih.gov/pubmed/17626072|https://www.ncbi.nlm.nih.gov/pubmed/18850583|https://www.ncbi.nlm.nih.gov/pubmed/19636294,15543232|17626072|18850583|19636294,,
70,1600529,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,7534,YWHAZ,https://ctdbase.org/detail.go?type=gene&acc=7534,,,7534.0,YWHAZ,9606,Homo sapiens (human),Bortezomib results in increased expression of YWHAZ mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
71,1600530,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,79842,ZBTB3,https://ctdbase.org/detail.go?type=gene&acc=79842,,,79842.0,ZBTB3,9606,Homo sapiens (human),Bortezomib results in increased expression of ZBTB3 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
72,1600531,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,54877,ZCCHC2,https://ctdbase.org/detail.go?type=gene&acc=54877,,,54877.0,ZCCHC2,9606,Homo sapiens (human),Bortezomib results in increased expression of ZCCHC2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
73,1600164,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3985,LIMK2,https://ctdbase.org/detail.go?type=gene&acc=3985,,,3985.0,LIMK2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LIMK2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
74,1600165,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,79727,LIN28A,https://ctdbase.org/detail.go?type=gene&acc=79727,,,79727.0,LIN28A,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LIN28A mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
75,1600757,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,284440,LINC00663,https://ctdbase.org/detail.go?type=gene&acc=284440,,,284440.0,LINC00663,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LINC00663 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
76,1600758,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100499466,LINC00674,https://ctdbase.org/detail.go?type=gene&acc=100499466,,,100499466.0,LINC00674,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LINC00674 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
77,1600759,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,349196,LINC00965,https://ctdbase.org/detail.go?type=gene&acc=349196,,,349196.0,LINC00965,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LINC00965 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
78,1600760,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,402483,LINC01000,https://ctdbase.org/detail.go?type=gene&acc=402483,,,402483.0,LINC01000,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LINC01000 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
79,1601379,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84823,LMNB2,https://ctdbase.org/detail.go?type=gene&acc=84823,,,84823.0,LMNB2,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of LMNB2 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
80,1601380,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4004,LMO1,https://ctdbase.org/detail.go?type=gene&acc=4004,,,4004.0,LMO1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LMO1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
81,1601381,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55885,LMO3,https://ctdbase.org/detail.go?type=gene&acc=55885,,,55885.0,LMO3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LMO3 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
82,1601382,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8543,LMO4,https://ctdbase.org/detail.go?type=gene&acc=8543,,,8543.0,LMO4,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of LMO4 mrna|methylmercuric chloride results in decreased expression of LMO4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
83,1601383,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,114412,LMO4A,https://ctdbase.org/detail.go?type=gene&acc=114412,,,114412.0,lmo4a,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of LMO4A mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
84,1601384,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4008,LMO7,https://ctdbase.org/detail.go?type=gene&acc=4008,,,4008.0,LMO7,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of LMO7 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
85,1601385,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4009,LMX1A,https://ctdbase.org/detail.go?type=gene&acc=4009,,,4009.0,LMX1A,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LMX1A mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
86,1601386,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4012,LNPEP,https://ctdbase.org/detail.go?type=gene&acc=4012,,,4012.0,LNPEP,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LNPEP mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
87,1601387,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80856,LNPK,https://ctdbase.org/detail.go?type=gene&acc=80856,,,80856.0,LNPK,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LNPK mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
88,1601388,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84708,LNX1,https://ctdbase.org/detail.go?type=gene&acc=84708,,,84708.0,LNX1,10090,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of LNX1 mRNA,,,PMID:20061341,https://www.ncbi.nlm.nih.gov/pubmed/20061341,20061341,,
89,1601571,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,222484,LNX2,https://ctdbase.org/detail.go?type=gene&acc=222484,,,222484.0,LNX2,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of LNX2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
90,1601975,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9404,LPXN,https://ctdbase.org/detail.go?type=gene&acc=9404,,,9404.0,LPXN,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LPXN mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
91,1601976,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,151354,LRATD1,https://ctdbase.org/detail.go?type=gene&acc=151354,,,151354.0,LRATD1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LRATD1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
92,1601977,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,987,LRBA,https://ctdbase.org/detail.go?type=gene&acc=987,,,987.0,LRBA,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LRBA mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
93,1601978,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57631,LRCH2,https://ctdbase.org/detail.go?type=gene&acc=57631,,,57631.0,LRCH2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LRCH2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
94,1601979,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84859,LRCH3,https://ctdbase.org/detail.go?type=gene&acc=84859,,,84859.0,LRCH3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LRCH3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
95,1601980,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,79414,LRFN3,https://ctdbase.org/detail.go?type=gene&acc=79414,,,79414.0,LRFN3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LRFN3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
96,1601981,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,145581,LRFN5,https://ctdbase.org/detail.go?type=gene&acc=145581,,,145581.0,LRFN5,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of LRFN5 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
97,1601982,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,116844,LRG1,https://ctdbase.org/detail.go?type=gene&acc=116844,,,116844.0,LRG1,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of LRG1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
98,1602554,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,94030,LRRC4B,https://ctdbase.org/detail.go?type=gene&acc=94030,,,94030.0,LRRC4B,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of LRRC4B mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
99,1602555,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100130742,LRRC69,https://ctdbase.org/detail.go?type=gene&acc=100130742,,,100130742.0,LRRC69,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of LRRC69 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
100,1602556,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100130742,LRRC69,https://ctdbase.org/detail.go?type=gene&acc=100130742,,,100130742.0,LRRC69,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of LRRC69 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
101,1602557,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100130733,LRRC70,https://ctdbase.org/detail.go?type=gene&acc=100130733,,,100130733.0,LRRC70,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LRRC70 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
102,1603161,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4055,LTBR,https://ctdbase.org/detail.go?type=gene&acc=4055,,,4055.0,LTBR,9606,Homo sapiens (human),Methylmercuric chloride promotes the reaction [OSM protein binds to LTBR protein],,,PMID:37193757,https://www.ncbi.nlm.nih.gov/pubmed/37193757,37193757,,
103,1603162,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4056,LTC4S,https://ctdbase.org/detail.go?type=gene&acc=4056,,,4056.0,LTC4S,10116,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride] results in decreased expression of LTC4S mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
104,1603163,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51747,LUC7L3,https://ctdbase.org/detail.go?type=gene&acc=51747,,,51747.0,LUC7L3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LUC7L3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
105,1603164,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4060,LUM,https://ctdbase.org/detail.go?type=gene&acc=4060,,,4060.0,LUM,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of LUM mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
106,1601652,439242,Comparative Toxicogenomics Database (CTD),Raffinose,D011887,Raffinose,https://ctdbase.org/detail.go?type=chem&acc=D011887,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090,Mus musculus (house mouse),Wortmannin inhibits the reaction [raffinose promotes the reaction [INS1 protein results in increased uptake of deoxyglucose]]|genistein inhibits the reaction [raffinose promotes the reaction [INS1 protein results in increased uptake of deoxyglucose]]|raffinose promotes the reaction [INS1 protein results in increased uptake of deoxyglucose],,,PMID:29458019,https://www.ncbi.nlm.nih.gov/pubmed/29458019,29458019,,
107,1601653,439242,Comparative Toxicogenomics Database (CTD),Raffinose,D011887,Raffinose,https://ctdbase.org/detail.go?type=chem&acc=D011887,3643,INSR,https://ctdbase.org/detail.go?type=gene&acc=3643,,,3643.0,INSR,10090,Mus musculus (house mouse),Raffinose results in increased phosphorylation of INSR protein,,,PMID:29458019,https://www.ncbi.nlm.nih.gov/pubmed/29458019,29458019,,
108,1601654,439242,Comparative Toxicogenomics Database (CTD),Raffinose,D011887,Raffinose,https://ctdbase.org/detail.go?type=chem&acc=D011887,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606,Homo sapiens (human),Raffinose results in increased expression of PPARA mRNA,,,PMID:29458019,https://www.ncbi.nlm.nih.gov/pubmed/29458019,29458019,,
109,1601655,439242,Comparative Toxicogenomics Database (CTD),Raffinose,D011887,Raffinose,https://ctdbase.org/detail.go?type=chem&acc=D011887,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10090,Mus musculus (house mouse),Raffinose results in increased expression of SLC2A4 protein,,,PMID:29458019,https://www.ncbi.nlm.nih.gov/pubmed/29458019,29458019,,
110,1601656,439242,Comparative Toxicogenomics Database (CTD),Raffinose,D011887,Raffinose,https://ctdbase.org/detail.go?type=chem&acc=D011887,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,9606,Homo sapiens (human),Raffinose results in decreased expression of SREBF1 mRNA,,,PMID:29458019,https://www.ncbi.nlm.nih.gov/pubmed/29458019,29458019,,
111,1602662,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,496,ATP4B,https://ctdbase.org/detail.go?type=gene&acc=496,,,496.0,ATP4B,9606,Homo sapiens (human),Ouabain inhibits the reaction [[ATP12A protein co-treated with ATP4B protein] results in increased uptake of rubidium],,,PMID:8853415,https://www.ncbi.nlm.nih.gov/pubmed/8853415,8853415,,
112,1602663,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,498,ATP5F1A,https://ctdbase.org/detail.go?type=gene&acc=498,,,498.0,ATP5F1A,9606,Homo sapiens (human),Ouabain affects the expression of ATP5F1A protein,,,PMID:17268060,https://www.ncbi.nlm.nih.gov/pubmed/17268060,17268060,,
113,1602664,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,545,ATR,https://ctdbase.org/detail.go?type=gene&acc=545,,,545.0,ATR,9606,Homo sapiens (human),Ouabain results in decreased phosphorylation of ATR protein,,,PMID:31436044,https://www.ncbi.nlm.nih.gov/pubmed/31436044,31436044,,
114,1602665,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,22893,BAHD1,https://ctdbase.org/detail.go?type=gene&acc=22893,,,22893.0,BAHD1,9606,Homo sapiens (human),Ouabain results in decreased expression of BAHD1 mRNA,,,PMID:16412265,https://www.ncbi.nlm.nih.gov/pubmed/16412265,16412265,,
115,1602666,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Ouabain affects the localization of BAX protein|ouabain inhibits the reaction [HSPD1 protein binds to BAX protein],,,PMID:18247327,https://www.ncbi.nlm.nih.gov/pubmed/18247327,18247327,,
116,1603879,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,9606,Homo sapiens (human),Ouabain affects the expression of LGALS1 protein,,,PMID:17268060,https://www.ncbi.nlm.nih.gov/pubmed/17268060,17268060,,
117,1603880,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,9606,Homo sapiens (human),Ouabain results in increased expression of LGALS1 protein,,,PMID:18247327,https://www.ncbi.nlm.nih.gov/pubmed/18247327,18247327,,
118,1603881,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3984,LIMK1,https://ctdbase.org/detail.go?type=gene&acc=3984,,,3984.0,LIMK1,9606,Homo sapiens (human),Ouabain results in decreased expression of LIMK1 mRNA,,,PMID:28795476,https://www.ncbi.nlm.nih.gov/pubmed/28795476,28795476,,
119,1603882,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [ouabain affects the localization of HIF1A protein]|ouabain results in increased phosphorylation of and results in increased expression of HIF1A protein|kn 93 inhibits the reaction [ouabain results in increased phosphorylation of HIF1A protein]|kn 93 inhibits the reaction [ouabain affects the localization of HIF1A protein]|ouabain affects the localization of HIF1A protein|ouabain results in increased activity of HIF1A protein|2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [ouabain affects the localization of HIF1A protein]|2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [ouabain results in increased phosphorylation of HIF1A protein],,,PMID:19647009,https://www.ncbi.nlm.nih.gov/pubmed/19647009,19647009,,
120,1603883,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3181,HNRNPA2B1,https://ctdbase.org/detail.go?type=gene&acc=3181,,,3181.0,HNRNPA2B1,9606,Homo sapiens (human),Ouabain affects the expression of HNRNPA2B1 protein,,,PMID:17268060,https://www.ncbi.nlm.nih.gov/pubmed/17268060,17268060,,
121,1603884,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,9987,HNRNPDL,https://ctdbase.org/detail.go?type=gene&acc=9987,,,9987.0,HNRNPDL,9606,Homo sapiens (human),Ouabain results in decreased expression of HNRNPDL mRNA,,,PMID:16412265,https://www.ncbi.nlm.nih.gov/pubmed/16412265,16412265,,
122,1603885,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3241,HPCAL1,https://ctdbase.org/detail.go?type=gene&acc=3241,,,3241.0,HPCAL1,9606,Homo sapiens (human),Ouabain affects the expression of HPCAL1 protein,,,PMID:17268060,https://www.ncbi.nlm.nih.gov/pubmed/17268060,17268060,,
123,1603886,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3273,HRG,https://ctdbase.org/detail.go?type=gene&acc=3273,,,3273.0,HRG,9606,Homo sapiens (human),Ouabain affects the expression of HRG protein,,,PMID:17268060,https://www.ncbi.nlm.nih.gov/pubmed/17268060,17268060,,
124,1603887,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606,Homo sapiens (human),Ouabain results in increased expression of HSPA5 protein,,,PMID:31436044,https://www.ncbi.nlm.nih.gov/pubmed/31436044,31436044,,
125,1604505,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116,Rattus norvegicus (Norway rat),"N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [ouabain results in increased expression of NPPA mrna]|ouabain results in increased expression of NPPA mRNA",,,PMID:19687166,https://www.ncbi.nlm.nih.gov/pubmed/19687166,19687166,,
126,1604506,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116,Rattus norvegicus (Norway rat),Ouabain promotes the reaction [phenylephrine results in increased expression of NPPA mrna],,,PMID:17266992,https://www.ncbi.nlm.nih.gov/pubmed/17266992,17266992,,
127,1600285,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,321943,UBE2L3B,https://ctdbase.org/detail.go?type=gene&acc=321943,,,321943.0,ube2l3b,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of UBE2L3B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
128,1600286,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9246,UBE2L6,https://ctdbase.org/detail.go?type=gene&acc=9246,,,9246.0,UBE2L6,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of UBE2L6 mRNA,,,PMID:12727804,https://www.ncbi.nlm.nih.gov/pubmed/12727804,12727804,,
129,1600287,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9040,UBE2M,https://ctdbase.org/detail.go?type=gene&acc=9040,,,9040.0,UBE2M,9606,Homo sapiens (human),Sodium arsenite promotes the reaction [UBE2M protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
130,1600288,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7334,UBE2N,https://ctdbase.org/detail.go?type=gene&acc=7334,,,7334.0,UBE2N,9606,Homo sapiens (human),Sodium arsenite results in increased expression of UBE2N mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
131,1600289,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7334,UBE2N,https://ctdbase.org/detail.go?type=gene&acc=7334,,,7334.0,UBE2N,9606,Homo sapiens (human),TP53 protein affects the reaction [sodium arsenite results in increased expression of UBE2N mrna],,,PMID:16966095,https://www.ncbi.nlm.nih.gov/pubmed/16966095,16966095,,
132,1600290,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100874097,UBE2Q1-AS1,https://ctdbase.org/detail.go?type=gene&acc=100874097,,,100874097.0,UBE2Q1-AS1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of UBE2Q1-AS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
133,1600291,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,92912,UBE2Q2,https://ctdbase.org/detail.go?type=gene&acc=92912,,,92912.0,UBE2Q2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of UBE2Q2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
134,1600292,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100134869,UBE2Q2P2,https://ctdbase.org/detail.go?type=gene&acc=100134869,,,100134869.0,UBE2Q2P2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of UBE2Q2P2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
135,1603647,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64718,UNKL,https://ctdbase.org/detail.go?type=gene&acc=64718,,,64718.0,UNKL,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of UNKL mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
136,1603648,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64718,UNKL,https://ctdbase.org/detail.go?type=gene&acc=64718,,,64718.0,UNKL,9606,Homo sapiens (human),Sodium arsenite results in increased expression of UNKL mRNA,,,PMID:25493608|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/25493608|https://www.ncbi.nlm.nih.gov/pubmed/29301061,25493608|29301061,,
137,1600644,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6187,RPS2,https://ctdbase.org/detail.go?type=gene&acc=6187,,,6187.0,RPS2,9606,Homo sapiens (human),Tretinoin results in increased expression of RPS2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
138,1600645,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6230,RPS25,https://ctdbase.org/detail.go?type=gene&acc=6230,,,6230.0,RPS25,9606,Homo sapiens (human),Tretinoin results in decreased expression of RPS25 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
139,1600646,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6233,RPS27A,https://ctdbase.org/detail.go?type=gene&acc=6233,,,6233.0,RPS27A,9606,Homo sapiens (human),Tretinoin results in decreased expression of RPS27A mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
140,1601037,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64121,RRAGC,https://ctdbase.org/detail.go?type=gene&acc=64121,,,64121.0,RRAGC,9606,Homo sapiens (human),Tretinoin results in increased expression of RRAGC mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
141,1601038,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6237,RRAS,https://ctdbase.org/detail.go?type=gene&acc=6237,,,6237.0,RRAS,9606,Homo sapiens (human),Tretinoin results in increased expression of RRAS mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
142,1601039,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6237,RRAS,https://ctdbase.org/detail.go?type=gene&acc=6237,,,6237.0,RRAS,10116,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of RRAS mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
143,1601040,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6238,RRBP1,https://ctdbase.org/detail.go?type=gene&acc=6238,,,6238.0,RRBP1,9606,Homo sapiens (human),Tretinoin results in increased expression of RRBP1 mRNA,,,PMID:16054129|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/16054129|https://www.ncbi.nlm.nih.gov/pubmed/33167477,16054129|33167477,,
144,1601041,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6240,RRM1,https://ctdbase.org/detail.go?type=gene&acc=6240,,,6240.0,RRM1,9606,Homo sapiens (human),Tretinoin results in decreased expression of RRM1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
145,1601042,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,7955,Danio rerio (zebrafish),Tretinoin results in increased expression of RRM2 mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
146,1601043,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,9606,Homo sapiens (human),Tretinoin results in decreased expression of RRM2 mRNA,,,PMID:15498508|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15498508|33167477,,
147,1601044,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8568,RRP1,https://ctdbase.org/detail.go?type=gene&acc=8568,,,8568.0,RRP1,9606,Homo sapiens (human),Tretinoin results in decreased expression of RRP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
148,1602096,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8607,RUVBL1,https://ctdbase.org/detail.go?type=gene&acc=8607,,,8607.0,RUVBL1,9606,Homo sapiens (human),Tretinoin results in decreased expression of RUVBL1 protein,,,PMID:17051635,https://www.ncbi.nlm.nih.gov/pubmed/17051635,17051635,,
149,1602097,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,9606,Homo sapiens (human),Thiophenes analog promotes the reaction [tretinoin results in decreased expression of RUVBL2 mrna],,,PMID:16140955,https://www.ncbi.nlm.nih.gov/pubmed/16140955,16140955,,
150,1602098,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,9606,Homo sapiens (human),Tretinoin results in decreased expression of RUVBL2 mRNA,,,PMID:16140955|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/16140955|https://www.ncbi.nlm.nih.gov/pubmed/23724009,16140955|23724009,,
151,1603303,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6271,S100A1,https://ctdbase.org/detail.go?type=gene&acc=6271,,,6271.0,S100A1,9606,Homo sapiens (human),Tretinoin metabolite results in decreased expression of S100A1 mRNA,,,PMID:15982314,https://www.ncbi.nlm.nih.gov/pubmed/15982314,15982314,,
152,1603304,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,9606,Homo sapiens (human),Tretinoin results in decreased expression of S100A10 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
153,1603305,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,9606,Homo sapiens (human),Tretinoin results in increased expression of S100A10 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
154,1603306,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,10090,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of S100A10 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
155,1603307,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,10090,Mus musculus (house mouse),Tretinoin results in decreased expression of S100A10 mRNA,,,PMID:16788091,https://www.ncbi.nlm.nih.gov/pubmed/16788091,16788091,,
156,1603308,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6282,S100A11,https://ctdbase.org/detail.go?type=gene&acc=6282,,,6282.0,S100A11,9606,Homo sapiens (human),Tretinoin results in increased expression of S100A11 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
157,1604695,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,6309,SC5D,https://ctdbase.org/detail.go?type=gene&acc=6309,,,6309.0,SC5D,7955,Danio rerio (zebrafish),Tretinoin results in decreased expression of SC5D mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
158,1602311,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,152518,NFXL1,https://ctdbase.org/detail.go?type=gene&acc=152518,,,152518.0,NFXL1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of NFXL1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
159,1602312,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4802,NFYC,https://ctdbase.org/detail.go?type=gene&acc=4802,,,4802.0,NFYC,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of NFYC mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
160,1602313,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [ethanol results in increased expression of NGF protein],,,PMID:23770283,https://www.ncbi.nlm.nih.gov/pubmed/23770283,23770283,,
161,1602314,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4804,NGFR,https://ctdbase.org/detail.go?type=gene&acc=4804,,,4804.0,NGFR,9606,Homo sapiens (human),Resveratrol results in increased expression of NGFR mrna|mir137 mRNA affects the reaction [resveratrol results in increased expression of NGFR mrna],,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
162,1602315,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55768,NGLY1,https://ctdbase.org/detail.go?type=gene&acc=55768,,,55768.0,NGLY1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of NGLY1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
163,1602316,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51335,NGRN,https://ctdbase.org/detail.go?type=gene&acc=51335,,,51335.0,NGRN,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of NGRN mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
164,1602317,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9351,NHERF2,https://ctdbase.org/detail.go?type=gene&acc=9351,,,9351.0,NHERF2,10090,Mus musculus (house mouse),Resveratrol results in decreased expression of NHERF2 mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
165,1604236,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:10188978|PMID:12175900|PMID:21284090,https://www.ncbi.nlm.nih.gov/pubmed/10188978|https://www.ncbi.nlm.nih.gov/pubmed/12175900|https://www.ncbi.nlm.nih.gov/pubmed/21284090,10188978|12175900|21284090,,
166,1604237,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [rotenone results in increased expression of NOS2 mrna],,,PMID:23593274|PMID:34391968,https://www.ncbi.nlm.nih.gov/pubmed/23593274|https://www.ncbi.nlm.nih.gov/pubmed/34391968,23593274|34391968,,
167,1604238,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [rotenone results in increased expression of NOS2 protein],,,PMID:34391968,https://www.ncbi.nlm.nih.gov/pubmed/34391968,34391968,,
168,1604507,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [cisplatin results in increased expression of NOS2 protein],,,PMID:33587916,https://www.ncbi.nlm.nih.gov/pubmed/33587916,33587916,,
169,1604508,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),Resveratrol results in decreased expression of NOS2 protein,,,PMID:14982945,https://www.ncbi.nlm.nih.gov/pubmed/14982945,14982945,,
170,1604509,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [dietary carbohydrates results in increased expression of NOS2 mrna]|resveratrol inhibits the reaction [plant preparations results in increased expression of NOS2 protein]|resveratrol inhibits the reaction [dietary carbohydrates results in increased expression of NOS2 protein]|resveratrol inhibits the reaction [plant preparations results in increased expression of NOS2 mrna],,,PMID:23872130,https://www.ncbi.nlm.nih.gov/pubmed/23872130,23872130,,
171,1604510,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [diethylnitrosamine results in increased expression of NOS2 protein],,,PMID:20501860,https://www.ncbi.nlm.nih.gov/pubmed/20501860,20501860,,
172,1604511,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [dimethylnitrosamine results in increased expression of NOS2 mrna],,,PMID:20422370,https://www.ncbi.nlm.nih.gov/pubmed/20422370,20422370,,
173,1604512,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [fructose results in increased expression of NOS2 protein]|resveratrol inhibits the reaction [fructose results in increased expression of NOS2 mrna],,,PMID:26488877,https://www.ncbi.nlm.nih.gov/pubmed/26488877,26488877,,
174,1604513,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [hydrogen peroxide results in increased expression of NOS2 protein],,,PMID:23691207,https://www.ncbi.nlm.nih.gov/pubmed/23691207,23691207,,
175,1600879,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,7851,MALL,https://ctdbase.org/detail.go?type=gene&acc=7851,,,7851.0,MALL,9606,Homo sapiens (human),Afimoxifene results in decreased expression of MALL mRNA,,,PMID:19901195,https://www.ncbi.nlm.nih.gov/pubmed/19901195,19901195,,
176,1600880,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,7851,MALL,https://ctdbase.org/detail.go?type=gene&acc=7851,,,7851.0,MALL,9606,Homo sapiens (human),Afimoxifene results in increased expression of MALL mRNA,,,PMID:19698761,https://www.ncbi.nlm.nih.gov/pubmed/19698761,19698761,,
177,1600881,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,149175,MANEAL,https://ctdbase.org/detail.go?type=gene&acc=149175,,,149175.0,MANEAL,9606,Homo sapiens (human),Afimoxifene inhibits the reaction [estrogens results in increased expression of MANEAL mrna],,,PMID:21233418,https://www.ncbi.nlm.nih.gov/pubmed/21233418,21233418,,
178,1600882,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606,Homo sapiens (human),Afimoxifene results in increased expression of MAP2K1 mRNA,,,PMID:12154049,https://www.ncbi.nlm.nih.gov/pubmed/12154049,12154049,,
179,1600883,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605.0,MAP2K2,9606,Homo sapiens (human),MAP2K2 results in decreased susceptibility to afimoxifene,,,PMID:21233418,https://www.ncbi.nlm.nih.gov/pubmed/21233418,21233418,,
180,1600884,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,5606,MAP2K3,https://ctdbase.org/detail.go?type=gene&acc=5606,,,5606.0,MAP2K3,9606,Homo sapiens (human),MAP2K3 results in decreased susceptibility to afimoxifene,,,PMID:21233418,https://www.ncbi.nlm.nih.gov/pubmed/21233418,21233418,,
181,1600885,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,6416,MAP2K4,https://ctdbase.org/detail.go?type=gene&acc=6416,,,6416.0,MAP2K4,9606,Homo sapiens (human),MAP2K4 results in decreased susceptibility to afimoxifene,,,PMID:21233418,https://www.ncbi.nlm.nih.gov/pubmed/21233418,21233418,,
182,1600886,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,5607,MAP2K5,https://ctdbase.org/detail.go?type=gene&acc=5607,,,5607.0,MAP2K5,9606,Homo sapiens (human),MAP2K5 results in decreased susceptibility to afimoxifene,,,PMID:21233418,https://www.ncbi.nlm.nih.gov/pubmed/21233418,21233418,,
183,1600887,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,5608,MAP2K6,https://ctdbase.org/detail.go?type=gene&acc=5608,,,5608.0,MAP2K6,9606,Homo sapiens (human),MAP2K6 results in decreased susceptibility to afimoxifene,,,PMID:21233418,https://www.ncbi.nlm.nih.gov/pubmed/21233418,21233418,,
184,1602667,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,10090,Mus musculus (house mouse),Afimoxifene binds to and results in increased activity of NR1I2 protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
185,1602668,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,3164,NR4A1,https://ctdbase.org/detail.go?type=gene&acc=3164,,,3164.0,NR4A1,9606,Homo sapiens (human),Afimoxifene results in increased expression of NR4A1 mRNA,,,PMID:16514628,https://www.ncbi.nlm.nih.gov/pubmed/16514628,16514628,,
186,1602669,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,4929,NR4A2,https://ctdbase.org/detail.go?type=gene&acc=4929,,,4929.0,NR4A2,9606,Homo sapiens (human),Afimoxifene results in increased expression of NR4A2 mrna|gper1 protein affects the reaction [afimoxifene results in increased expression of NR4A2 mrna],,,PMID:19153601,https://www.ncbi.nlm.nih.gov/pubmed/19153601,19153601,,
187,1602670,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [afimoxifene results in increased expression of NRF1 mrna]|afimoxifene results in increased expression of NRF1 mrna|vehicle emissions inhibits the reaction [afimoxifene results in increased expression of NRF1 mrna],,,PMID:22105178,https://www.ncbi.nlm.nih.gov/pubmed/22105178,22105178,,
188,1603656,449459,Comparative Toxicogenomics Database (CTD),Afimoxifene,C016601,afimoxifene,https://ctdbase.org/detail.go?type=chem&acc=C016601,84919,PPP1R15B,https://ctdbase.org/detail.go?type=gene&acc=84919,,,84919.0,PPP1R15B,9606,Homo sapiens (human),PPP1R15B gene affects the susceptibility to afimoxifene,,,PMID:21482774,https://www.ncbi.nlm.nih.gov/pubmed/21482774,21482774,,
189,1600166,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,3921,RPSA,https://ctdbase.org/detail.go?type=gene&acc=3921,,,3921.0,RPSA,9606,Homo sapiens (human),Decitabine results in decreased expression of RPSA mrna|tp53 protein affects the reaction [decitabine results in decreased expression of RPSA mrna],,,PMID:19363521,https://www.ncbi.nlm.nih.gov/pubmed/19363521,19363521,,
190,1600167,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,285367,RPUSD3,https://ctdbase.org/detail.go?type=gene&acc=285367,,,285367.0,RPUSD3,9606,Homo sapiens (human),Decitabine affects the expression of RPUSD3 mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
191,1600168,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,6236,RRAD,https://ctdbase.org/detail.go?type=gene&acc=6236,,,6236.0,RRAD,9606,Homo sapiens (human),Decitabine affects the expression of RRAD mRNA,,,PMID:17195088,https://www.ncbi.nlm.nih.gov/pubmed/17195088,17195088,,
192,1600169,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,58528,RRAGD,https://ctdbase.org/detail.go?type=gene&acc=58528,,,58528.0,RRAGD,9606,Homo sapiens (human),Decitabine affects the expression of RRAGD mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
193,1600170,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,6237,RRAS,https://ctdbase.org/detail.go?type=gene&acc=6237,,,6237.0,RRAS,9606,Homo sapiens (human),Decitabine affects the expression of RRAS mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
194,1600171,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,22800,RRAS2,https://ctdbase.org/detail.go?type=gene&acc=22800,,,22800.0,RRAS2,9606,Homo sapiens (human),Decitabine affects the expression of RRAS2 mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
195,1600172,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,50484,RRM2B,https://ctdbase.org/detail.go?type=gene&acc=50484,,,50484.0,RRM2B,9606,Homo sapiens (human),Decitabine results in increased expression of RRM2B protein|tp53 protein affects the reaction [decitabine results in increased expression of RRM2B mrna]|decitabine results in increased expression of RRM2B mRNA,,,PMID:19010910,https://www.ncbi.nlm.nih.gov/pubmed/19010910,19010910,,
196,1600173,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,23223,RRP12,https://ctdbase.org/detail.go?type=gene&acc=23223,,,23223.0,RRP12,9606,Homo sapiens (human),Decitabine affects the expression of RRP12 mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
197,1600174,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,27341,RRP7A,https://ctdbase.org/detail.go?type=gene&acc=27341,,,27341.0,RRP7A,9606,Homo sapiens (human),Decitabine results in increased expression of RRP7A mRNA,,,PMID:17908484,https://www.ncbi.nlm.nih.gov/pubmed/17908484,17908484,,
198,1600381,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,6257,RXRB,https://ctdbase.org/detail.go?type=gene&acc=6257,,,6257.0,RXRB,9606,Homo sapiens (human),Decitabine results in increased expression of RXRB mRNA,,,PMID:17908484,https://www.ncbi.nlm.nih.gov/pubmed/17908484,17908484,,
199,1600382,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,6261,RYR1,https://ctdbase.org/detail.go?type=gene&acc=6261,,,6261.0,RYR1,9606,Homo sapiens (human),Decitabine inhibits the reaction [smoke results in decreased expression of RYR1 mrna],,,PMID:21095227,https://www.ncbi.nlm.nih.gov/pubmed/21095227,21095227,,
200,1600383,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,9606,Homo sapiens (human),Decitabine affects the expression of S100A10 mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
201,1602222,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,6424,SFRP4,https://ctdbase.org/detail.go?type=gene&acc=6424,,,6424.0,SFRP4,9606,Homo sapiens (human),[decitabine affects the methylation of SFRP4] which affects the expression of SFRP4 mRNA,,,PMID:17463086,https://www.ncbi.nlm.nih.gov/pubmed/17463086,17463086,,
202,1602223,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,6424,SFRP4,https://ctdbase.org/detail.go?type=gene&acc=6424,,,6424.0,SFRP4,9606,Homo sapiens (human),[decitabine co-treated with trichostatin A] results in increased expression of SFRP4 mRNA,,,PMID:17923031,https://www.ncbi.nlm.nih.gov/pubmed/17923031,17923031,,
203,1603778,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,10116,Rattus norvegicus (Norway rat),Decitabine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein],,,PMID:24211420,https://www.ncbi.nlm.nih.gov/pubmed/24211420,24211420,,
204,1603779,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4090,SMAD5,https://ctdbase.org/detail.go?type=gene&acc=4090,,,4090.0,SMAD5,10090,Mus musculus (house mouse),Decitabine results in decreased expression of SMAD5 mRNA,,,PMID:27915011,https://www.ncbi.nlm.nih.gov/pubmed/27915011,27915011,,
205,1603780,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4092,SMAD7,https://ctdbase.org/detail.go?type=gene&acc=4092,,,4092.0,SMAD7,9606,Homo sapiens (human),Decitabine results in increased expression of SMAD7 mRNA,,,PMID:19194470,https://www.ncbi.nlm.nih.gov/pubmed/19194470,19194470,,
206,1603781,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4092,SMAD7,https://ctdbase.org/detail.go?type=gene&acc=4092,,,4092.0,SMAD7,10116,Rattus norvegicus (Norway rat),Decitabine inhibits the reaction [TGFB1 protein results in decreased expression of SMAD7 mrna]|decitabine inhibits the reaction [TGFB1 protein results in increased methylation of SMAD7 promoter]|decitabine inhibits the reaction [TGFB1 protein results in decreased expression of SMAD7 protein],,,PMID:24211420,https://www.ncbi.nlm.nih.gov/pubmed/24211420,24211420,,
207,1603782,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,4093,SMAD9,https://ctdbase.org/detail.go?type=gene&acc=4093,,,4093.0,SMAD9,10090,Mus musculus (house mouse),Decitabine results in decreased expression of SMAD9 mRNA,,,PMID:27915011,https://www.ncbi.nlm.nih.gov/pubmed/27915011,27915011,,
208,1603783,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,57228,SMAGP,https://ctdbase.org/detail.go?type=gene&acc=57228,,,57228.0,SMAGP,9606,Homo sapiens (human),Decitabine affects the expression of SMAGP mRNA,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,
209,1601045,457193,Comparative Toxicogenomics Database (CTD),Dactinomycin,D003609,Dactinomycin,https://ctdbase.org/detail.go?type=chem&acc=D003609,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10116,Rattus norvegicus (Norway rat),Dactinomycin inhibits the reaction [coptisine results in increased expression of ABCB1A mrna],,,PMID:20410605,https://www.ncbi.nlm.nih.gov/pubmed/20410605,20410605,,
210,1603309,457193,Comparative Toxicogenomics Database (CTD),Dactinomycin,D003609,Dactinomycin,https://ctdbase.org/detail.go?type=chem&acc=D003609,79789,CLMN,https://ctdbase.org/detail.go?type=gene&acc=79789,,,79789.0,CLMN,9606,Homo sapiens (human),Dactinomycin inhibits the reaction [tretinoin results in increased expression of CLMN mrna],,,PMID:16688769,https://www.ncbi.nlm.nih.gov/pubmed/16688769,16688769,,
211,1603310,457193,Comparative Toxicogenomics Database (CTD),Dactinomycin,D003609,Dactinomycin,https://ctdbase.org/detail.go?type=chem&acc=D003609,11061,CNMD,https://ctdbase.org/detail.go?type=gene&acc=11061,,,11061.0,CNMD,9606,Homo sapiens (human),Dactinomycin inhibits the reaction [hydroquinone results in increased expression of CNMD protein],,,PMID:19525446,https://www.ncbi.nlm.nih.gov/pubmed/19525446,19525446,,
212,1603311,457193,Comparative Toxicogenomics Database (CTD),Dactinomycin,D003609,Dactinomycin,https://ctdbase.org/detail.go?type=chem&acc=D003609,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,9606,Homo sapiens (human),Dactinomycin inhibits the reaction [gemcitabine results in increased expression of CNR1 mrna],,,PMID:21525939,https://www.ncbi.nlm.nih.gov/pubmed/21525939,21525939,,
213,1602090,461217,BindingDB,"(3S,4aS,8aS)-2-[(2R,3S)-3-[[(2S)-2-acetamido-3-naphthalen-2-ylsulfonylpropanoyl]amino]-2-hydroxy-4-phenylbutyl]-N-tert-butyl-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide",812,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-2-acetamido-3-(naphthalene-2-sulfonyl)propanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=812,223,Gag-Pol polyprotein [489-587],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=223,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),1.6,,,,,
214,1602091,461218,BindingDB,"(3S,4aS,8aS)-2-[(2R,3S)-3-[[(2S)-2-acetamido-3-quinolin-8-ylsulfonylpropanoyl]amino]-2-hydroxy-4-phenylbutyl]-N-tert-butyl-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide",813,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-2-acetamido-3-(quinoline-8-sulfonyl)propanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=813,223,Gag-Pol polyprotein [489-587],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=223,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),1.7,,,,,
215,1602092,461218,BindingDB,"(3S,4aS,8aS)-2-[(2R,3S)-3-[[(2S)-2-acetamido-3-quinolin-8-ylsulfonylpropanoyl]amino]-2-hydroxy-4-phenylbutyl]-N-tert-butyl-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide",813,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-2-acetamido-3-(quinoline-8-sulfonyl)propanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=813,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),1.7,,,,,
216,1602093,461219,BindingDB,"3-Isoquinolinecarboxamide, 2-(3-((2-(acetylamino)-1-oxo-3-((phenylmethyl)thio)propyl)amino)-2-hydroxy-4-phenylbutyl)-N-(1,1-dimethylethyl)decahydro-, (3S-(2(2S*,3R*(R*)),3a,4ab,8ab))-",814,"(3S,4aS,8aS)-2-[(2R,3S)-3-[(2S)-3-(benzylsulfanyl)-2-acetamidopropanamido]-2-hydroxy-4-phenylbutyl]-N-tert-butyl-decahydroisoquinoline-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=814,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),6.0,,,,,
217,1602094,461219,BindingDB,"3-Isoquinolinecarboxamide, 2-(3-((2-(acetylamino)-1-oxo-3-((phenylmethyl)thio)propyl)amino)-2-hydroxy-4-phenylbutyl)-N-(1,1-dimethylethyl)decahydro-, (3S-(2(2S*,3R*(R*)),3a,4ab,8ab))-",814,"(3S,4aS,8aS)-2-[(2R,3S)-3-[(2S)-3-(benzylsulfanyl)-2-acetamidopropanamido]-2-hydroxy-4-phenylbutyl]-N-tert-butyl-decahydroisoquinoline-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=814,223,Gag-Pol polyprotein [489-587],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=223,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),6,,,,,
218,1602095,461220,BindingDB,"Thieno(3,2-c)pyridine-6-carboxamide, 5-(3-((2-(acetylamino)-3-((4-fluorophenyl)sulfonyl)-1-oxopropyl)amino)-2-hydroxy-4-phenylbutyl)-N-(1,1-dimethylethyl)octahydro-, (3aR-(3aalpha,5(2R*,3S*(S*)),6beta,7aalpha))-",815,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-3-[(2S)-2-acetamido-3-[(4-fluorobenzene)sulfonyl]propanamido]-2-hydroxy-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=815,223,Gag-Pol polyprotein [489-587],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=223,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),1.2,,,,,
219,1600638,462958,BindingDB,"1-((5-Methanesulfonamidoindol-2-yl)carbonyl)-4-(N-methyl-N-(3-((1,1-dimethylethyl)amino)-2-pyridinyl)amino)piperidine",1951,(Alkylamino)piperidine BHAP Analog 7,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1951,76,"Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=76,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),510,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
220,1600639,462958,BindingDB,"1-((5-Methanesulfonamidoindol-2-yl)carbonyl)-4-(N-methyl-N-(3-((1,1-dimethylethyl)amino)-2-pyridinyl)amino)piperidine",1951,(Alkylamino)piperidine BHAP Analog 7,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1951,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),390,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
221,1600640,462960,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[3-[(cyclopropylmethyl)amino]-2-pyridinyl]amino]piperidine,1953,(Alkylamino)piperidine BHAP Analog 9,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1953,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),520,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
222,1600641,462960,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[3-[(cyclopropylmethyl)amino]-2-pyridinyl]amino]piperidine,1953,(Alkylamino)piperidine BHAP Analog 9,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1953,80,"Gag-Pol polyprotein [588-1027,P823L]/[588-1147,P823L]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=80,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),14600,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
223,1600642,462960,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[3-[(cyclopropylmethyl)amino]-2-pyridinyl]amino]piperidine,1953,(Alkylamino)piperidine BHAP Analog 9,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1953,76,"Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=76,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),2910,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
224,1600643,462961,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[3-(cyclopropylamino)-2-pyridinyl]amino]piperidine,1954,(Alkylamino)piperidine BHAP Analog 10,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1954,76,"Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=76,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),280,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
225,1601851,462980,BindingDB,N-[2-({4-[[3-(Isopropylamino)pyridin-2-yl](propyl)amino]piperidin-1-yl}carbonyl)-1H-indol-5-yl]-4-methylpiperazine-1-carboxamide,2661,(Alkylamino)piperidine BHAP Analog 29,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2661,80,"Gag-Pol polyprotein [588-1027,P823L]/[588-1147,P823L]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=80,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),400,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
226,1601852,462980,BindingDB,N-[2-({4-[[3-(Isopropylamino)pyridin-2-yl](propyl)amino]piperidin-1-yl}carbonyl)-1H-indol-5-yl]-4-methylpiperazine-1-carboxamide,2661,(Alkylamino)piperidine BHAP Analog 29,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2661,76,"Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=76,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),860,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
227,1601853,462980,BindingDB,N-[2-({4-[[3-(Isopropylamino)pyridin-2-yl](propyl)amino]piperidin-1-yl}carbonyl)-1H-indol-5-yl]-4-methylpiperazine-1-carboxamide,2661,(Alkylamino)piperidine BHAP Analog 29,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2661,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),190,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
228,1601854,462981,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[3-(isopropylamino)-2-pyridazinyl]amino]piperidine,2662,(Alkylamino)piperidine BHAP Analog 30,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2662,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),740,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
229,1601855,462981,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[3-(isopropylamino)-2-pyridazinyl]amino]piperidine,2662,(Alkylamino)piperidine BHAP Analog 30,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2662,76,"Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=76,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),1310,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
230,1601856,462981,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[3-(isopropylamino)-2-pyridazinyl]amino]piperidine,2662,(Alkylamino)piperidine BHAP Analog 30,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2662,80,"Gag-Pol polyprotein [588-1027,P823L]/[588-1147,P823L]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=80,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),4560,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
231,1601857,462982,BindingDB,1-[(5-Methanesulfonamidoindol-2-yl)carbonyl]-4-[N-methyl-N-[6-chloro-3-[(1-methylethyl)amino]-2-pyridinyl]amino]piperidine,2663,(Alkylamino)piperidine BHAP Analog 31,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2663,80,"Gag-Pol polyprotein [588-1027,P823L]/[588-1147,P823L]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=80,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),1700,PMID:8809165|DOI:10.1021/jm960158n,https://www.ncbi.nlm.nih.gov/pubmed/8809165|https://doi.org/10.1021/jm960158n,8809165,10.1021/jm960158n,
232,1602549,463144,BindingDB,Dipyridodiazepinone deriv. 15,1528,"5-chloro-2-ethyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1528,66,"Gag-Pol polyprotein [600-1027,Y780C]/[600-1155,Y780C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=66,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),800,PMID:7490732|DOI:10.1021/jm00024a010,https://www.ncbi.nlm.nih.gov/pubmed/7490732|https://doi.org/10.1021/jm00024a010,7490732,10.1021/jm00024a010,
233,1602550,463145,BindingDB,Dipyridodiazepinone deriv. 18,1531,"2-Bromo-11-cyclopropyl-5-methyl-5,11-dihydro-6H-dipyridio[3,2-b:2 ,3 -e][1,4]diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1531,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),30,PMID:7490732|DOI:10.1021/jm00024a010,https://www.ncbi.nlm.nih.gov/pubmed/7490732|https://doi.org/10.1021/jm00024a010,7490732,10.1021/jm00024a010,
234,1602551,463145,BindingDB,Dipyridodiazepinone deriv. 18,1531,"2-Bromo-11-cyclopropyl-5-methyl-5,11-dihydro-6H-dipyridio[3,2-b:2 ,3 -e][1,4]diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1531,66,"Gag-Pol polyprotein [600-1027,Y780C]/[600-1155,Y780C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=66,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),2100,PMID:7490732|DOI:10.1021/jm00024a010,https://www.ncbi.nlm.nih.gov/pubmed/7490732|https://doi.org/10.1021/jm00024a010,7490732,10.1021/jm00024a010,
235,1602552,463146,BindingDB,Dipyridodiazepinone deriv. 19,1532,"5-amino-2-ethyl-9-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1532,66,"Gag-Pol polyprotein [600-1027,Y780C]/[600-1155,Y780C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=66,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),>1000,PMID:7490732|DOI:10.1021/jm00024a010,https://www.ncbi.nlm.nih.gov/pubmed/7490732|https://doi.org/10.1021/jm00024a010,7490732,10.1021/jm00024a010,
236,1602553,463146,BindingDB,Dipyridodiazepinone deriv. 19,1532,"5-amino-2-ethyl-9-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1532,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),>1000,PMID:7490732|DOI:10.1021/jm00024a010,https://www.ncbi.nlm.nih.gov/pubmed/7490732|https://doi.org/10.1021/jm00024a010,7490732,10.1021/jm00024a010,
237,1602788,463191,BindingDB,Dipyridodiazepinone deriv. 64,1573,"2-cyclopropyl-9-methyl-5-(pyridin-3-yl)-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1573,66,"Gag-Pol polyprotein [600-1027,Y780C]/[600-1155,Y780C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=66,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),440,PMID:7490732|DOI:10.1021/jm00024a010,https://www.ncbi.nlm.nih.gov/pubmed/7490732|https://doi.org/10.1021/jm00024a010,7490732,10.1021/jm00024a010,
238,1602789,463191,BindingDB,Dipyridodiazepinone deriv. 64,1573,"2-cyclopropyl-9-methyl-5-(pyridin-3-yl)-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1573,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),180,PMID:7490732|DOI:10.1021/jm00024a010,https://www.ncbi.nlm.nih.gov/pubmed/7490732|https://doi.org/10.1021/jm00024a010,7490732,10.1021/jm00024a010,
239,1603649,463276,BindingDB,"12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-3-((2-hydroxyphenyl)methyl)-13,13-dimethyl-11-oxo-9-(phenylmethyl)-, 1,1-dimethylethyl ester, (3S-(3R*,4S*,8S*,9R*))-",669,BMS-186318 analog 6,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=669,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),300,PMID:8642558|DOI:10.1021/jm950717a,https://www.ncbi.nlm.nih.gov/pubmed/8642558|https://doi.org/10.1021/jm950717a,8642558,10.1021/jm950717a,
240,1603650,463277,BindingDB,"12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-3-((4-(2-(1H-imidazol-1-yl)ethoxy)phenyl)methyl)-13,13-dimethyl-11-oxo-9-(phenylmethyl)-, 1,1-dimethylethyl ester, (3S-(3R*,4S*,8S*,9R*))-",670,BMS-186318 analog 7,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=670,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),90,PMID:8642558|DOI:10.1021/jm950717a,https://www.ncbi.nlm.nih.gov/pubmed/8642558|https://doi.org/10.1021/jm950717a,8642558,10.1021/jm950717a,
241,1603651,463278,BindingDB,"12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-13,13-dimethyl-11-oxo-3-(phenylmethyl)-9-((4-(2-(2-pyridinyl)ethoxy)phenyl)methyl)-, 1,1-dimethylethyl ester, (3S-(3R*,4S*,8S*,9R*))-",671,BMS-186318 analog 8,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=671,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),50,PMID:8642558|DOI:10.1021/jm950717a,https://www.ncbi.nlm.nih.gov/pubmed/8642558|https://doi.org/10.1021/jm950717a,8642558,10.1021/jm950717a,
242,1603652,463279,BindingDB,"(1S-(1R,2S(2S,3R)))-(3-((3-(((1,1-Dimethylethoxy)-carbonyl)amino)-2-hydroxy-4-(4-(2-(3-pyridinyloxy)ethoxy)phenyl)butyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamic Acid, 1,1-Dimethylethyl ester",672,"(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=672,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),60,PMID:8642558|DOI:10.1021/jm950717a,https://www.ncbi.nlm.nih.gov/pubmed/8642558|https://doi.org/10.1021/jm950717a,8642558,10.1021/jm950717a,
243,1603653,463280,BindingDB,"12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-3-((4-(2-hydroxy-2-(3-pyridinyl)ethoxy)phenyl)methyl)-13,13-dimethyl-11-oxo-9-(phenylmethyl)-, 1,1-dimethylethyl ester",673,"(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=673,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),110,PMID:8642558|DOI:10.1021/jm950717a,https://www.ncbi.nlm.nih.gov/pubmed/8642558|https://doi.org/10.1021/jm950717a,8642558,10.1021/jm950717a,
244,1603654,463281,BindingDB,"12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-3-((4-(2-hydroxyethoxy)phenyl)methyl)-13,13-dimethyl-11-oxo-9-(phenylmethyl)-, 1,1-dimethylethyl ester, (3S-(3R*,4S*,8S*,9R*))-",674,BMS-186318 analog 11,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=674,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),64,PMID:8642558|DOI:10.1021/jm950717a,https://www.ncbi.nlm.nih.gov/pubmed/8642558|https://doi.org/10.1021/jm950717a,8642558,10.1021/jm950717a,
245,1603655,463282,BindingDB,"12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-3-((4-(2-methoxyethoxy)phenyl)methyl)-13,13-dimethyl-11-oxo-9-(phenylmethyl)-, 1,1-dimethylethyl ester, (3S-(3R*,4S*,8S*,9R*))-",675,BMS-186318 analog 12,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=675,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),72,PMID:8642558|DOI:10.1021/jm950717a,https://www.ncbi.nlm.nih.gov/pubmed/8642558|https://doi.org/10.1021/jm950717a,8642558,10.1021/jm950717a,
246,1604696,464535,BindingDB,Nevirapin 4-substituted deriv. 4o,1592,"11-C yclopropyl-5,l l-dihydro-4-( 14midazolylmethyl)-6H-dipyrido[3,2-b:2 ,3 -e] [ 1,4]diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1592,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,,,PMID:7490733|DOI:10.1021/jm00024a011,https://www.ncbi.nlm.nih.gov/pubmed/7490733|https://doi.org/10.1021/jm00024a011,7490733,10.1021/jm00024a011,
247,1604697,464536,BindingDB,Nevirapin 4-substituted deriv. 4p,1593,"1 1 -Cyclopropyl-5,11 hydro-4- [ [ (2-methylpheny1)oxy]-methyl]-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1593,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),290,PMID:7490733|DOI:10.1021/jm00024a011,https://www.ncbi.nlm.nih.gov/pubmed/7490733|https://doi.org/10.1021/jm00024a011,7490733,10.1021/jm00024a011,
248,1604698,464537,BindingDB,Nevirapin 4-substituted deriv. 4q,1594,"1 1-Cyclopropyl-5,l l-dihydro-4-[[(3-methylphenyl)oxy]-methyl] -6H-dipyrido[3,2-b:2 ,3 -e] [ 1,4] diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1594,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),2430,PMID:7490733|DOI:10.1021/jm00024a011,https://www.ncbi.nlm.nih.gov/pubmed/7490733|https://doi.org/10.1021/jm00024a011,7490733,10.1021/jm00024a011,
249,1604699,464538,BindingDB,Nevirapin 4-substituted deriv. 4r,1595,"11-Cyclopropyl-5,l-dihydr0-4-[ [ (4-methylpheny1)oxy]-methyl] -6H-dipyrido[3,2-b:2 ,3 -e] [ 1,4]diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1595,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),580,PMID:7490733|DOI:10.1021/jm00024a011,https://www.ncbi.nlm.nih.gov/pubmed/7490733|https://doi.org/10.1021/jm00024a011,7490733,10.1021/jm00024a011,
250,1604700,464539,BindingDB,Nevirapin 4-substituted deriv. 4s,1596,"1 1 -C yclopropyl-5,ll -dihydro-4- [ [ (2-hydroxyphenyl)-oxy]methyl]-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1596,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),460,PMID:7490733|DOI:10.1021/jm00024a011,https://www.ncbi.nlm.nih.gov/pubmed/7490733|https://doi.org/10.1021/jm00024a011,7490733,10.1021/jm00024a011,
251,1602224,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,51560,RAB6B,https://ctdbase.org/detail.go?type=gene&acc=51560,,,51560.0,RAB6B,9606,Homo sapiens (human),[cuprizone co-treated with cannabidiol] results in increased expression of RAB6B protein,,,PMID:34122009,https://www.ncbi.nlm.nih.gov/pubmed/34122009,34122009,,
252,1602225,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,338382,RAB7B,https://ctdbase.org/detail.go?type=gene&acc=338382,,,338382.0,RAB7B,9606,Homo sapiens (human),[APP protein affects the susceptibility to cannabidiol] which affects the expression of RAB7B mrna|[psen1 protein affects the susceptibility to cannabidiol] which affects the expression of RAB7B mRNA,,,PMID:33096116,https://www.ncbi.nlm.nih.gov/pubmed/33096116,33096116,,
253,1602226,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606,Homo sapiens (human),Cannabidiol inhibits the reaction [TNF protein results in increased expression of RAC1 mrna],,,PMID:31250491,https://www.ncbi.nlm.nih.gov/pubmed/31250491,31250491,,
254,1602227,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606,Homo sapiens (human),[oxygen co-treated with ozone co-treated with cannabidiol] results in decreased expression of RAC1 mRNA,,,PMID:32992648,https://www.ncbi.nlm.nih.gov/pubmed/32992648,32992648,,
255,1603156,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364.0,CCL20,9606,Homo sapiens (human),Cannabidiol results in increased expression of CCL20 mRNA,,,PMID:33244087|PMID:36519830,https://www.ncbi.nlm.nih.gov/pubmed/33244087|https://www.ncbi.nlm.nih.gov/pubmed/36519830,33244087|36519830,,
256,1603157,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,100192217,CCL20A.3,https://ctdbase.org/detail.go?type=gene&acc=100192217,,,100192217.0,ccl20a.3,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of CCL20A.3 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
257,1603158,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6367,CCL22,https://ctdbase.org/detail.go?type=gene&acc=6367,,,6367.0,CCL22,9606,Homo sapiens (human),Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL22 mrna],,,PMID:31250491,https://www.ncbi.nlm.nih.gov/pubmed/31250491,31250491,,
258,1603159,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6367,CCL22,https://ctdbase.org/detail.go?type=gene&acc=6367,,,6367.0,CCL22,10090,Mus musculus (house mouse),"[lipopolysaccharide, E coli O55-B5 co-treated with cannabidiol] results in decreased expression of CCL22 mRNA",,,PMID:30742662,https://www.ncbi.nlm.nih.gov/pubmed/30742662,30742662,,
259,1603160,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,10344,CCL26,https://ctdbase.org/detail.go?type=gene&acc=10344,,,10344.0,CCL26,9606,Homo sapiens (human),Cannabidiol inhibits the reaction [TNF protein results in decreased expression of CCL26 mrna],,,PMID:31250491,https://www.ncbi.nlm.nih.gov/pubmed/31250491,31250491,,
260,1603435,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,10535,RNASEH2A,https://ctdbase.org/detail.go?type=gene&acc=10535,,,10535.0,RNASEH2A,9606,Homo sapiens (human),Cannabidiol results in decreased expression of RNASEH2A mRNA,,,PMID:36519830,https://www.ncbi.nlm.nih.gov/pubmed/36519830,36519830,,
261,1603436,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,390,RND3,https://ctdbase.org/detail.go?type=gene&acc=390,,,390.0,RND3,9606,Homo sapiens (human),Cannabidiol results in increased expression of RND3 mRNA,,,PMID:26504004|PMID:33244087,https://www.ncbi.nlm.nih.gov/pubmed/26504004|https://www.ncbi.nlm.nih.gov/pubmed/33244087,26504004|33244087,,
262,1603437,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,390,RND3,https://ctdbase.org/detail.go?type=gene&acc=390,,,390.0,RND3,9606,Homo sapiens (human),[dronabinol co-treated with cannabidiol] results in increased expression of RND3 mRNA,,,PMID:26504004,https://www.ncbi.nlm.nih.gov/pubmed/26504004,26504004,,
263,1603528,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),Cannabidiol promotes the reaction [[oxygen co-treated with ozone] results in decreased expression of CCNB1 mrna],,,PMID:32992648,https://www.ncbi.nlm.nih.gov/pubmed/32992648,32992648,,
264,1603529,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),Cannabidiol results in decreased expression of CCNB1 mRNA,,,PMID:36519830,https://www.ncbi.nlm.nih.gov/pubmed/36519830,36519830,,
265,1603530,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,9133,CCNB2,https://ctdbase.org/detail.go?type=gene&acc=9133,,,9133.0,CCNB2,9606,Homo sapiens (human),Cannabidiol results in decreased expression of CCNB2 mRNA,,,PMID:36519830,https://www.ncbi.nlm.nih.gov/pubmed/36519830,36519830,,
266,1603531,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of CCND1 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
267,1603532,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Cannabidiol promotes the reaction [[oxygen co-treated with ozone] results in decreased expression of CCND1 mrna],,,PMID:32992648,https://www.ncbi.nlm.nih.gov/pubmed/32992648,32992648,,
268,1603533,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Cannabidiol results in decreased expression of CCND1 protein,,,PMID:30007266|PMID:34871667|PMID:36810933,https://www.ncbi.nlm.nih.gov/pubmed/30007266|https://www.ncbi.nlm.nih.gov/pubmed/34871667|https://www.ncbi.nlm.nih.gov/pubmed/36810933,30007266|34871667|36810933,,
269,1603534,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090,Mus musculus (house mouse),Cannabidiol results in decreased expression of CCND1 mRNA,,,PMID:21542829|PMID:30742662,https://www.ncbi.nlm.nih.gov/pubmed/21542829|https://www.ncbi.nlm.nih.gov/pubmed/30742662,21542829|30742662,,
270,1603784,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,101882236,RP1L1A,https://ctdbase.org/detail.go?type=gene&acc=101882236,,,101882236.0,rp1l1a,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of RP1L1A mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
271,1603785,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6117,RPA1,https://ctdbase.org/detail.go?type=gene&acc=6117,,,6117.0,RPA1,9606,Homo sapiens (human),Cannabidiol results in decreased expression of RPA1 mRNA,,,PMID:36519830,https://www.ncbi.nlm.nih.gov/pubmed/36519830,36519830,,
272,1603786,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6118,RPA2,https://ctdbase.org/detail.go?type=gene&acc=6118,,,6118.0,RPA2,9606,Homo sapiens (human),Cannabidiol results in decreased expression of RPA2 mRNA,,,PMID:36519830,https://www.ncbi.nlm.nih.gov/pubmed/36519830,36519830,,
273,1603985,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6181,RPLP2,https://ctdbase.org/detail.go?type=gene&acc=6181,,,6181.0,RPLP2,10090,Mus musculus (house mouse),Cannabidiol results in increased expression of RPLP2 mRNA,,,PMID:31052254,https://www.ncbi.nlm.nih.gov/pubmed/31052254,31052254,,
274,1603986,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6206,RPS12,https://ctdbase.org/detail.go?type=gene&acc=6206,,,6206.0,RPS12,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of RPS12 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
275,1603987,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6206,RPS12,https://ctdbase.org/detail.go?type=gene&acc=6206,,,6206.0,RPS12,9606,Homo sapiens (human),Cannabidiol results in increased expression of RPS12 protein,,,PMID:34122009,https://www.ncbi.nlm.nih.gov/pubmed/34122009,34122009,,
276,1603988,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6223,RPS19,https://ctdbase.org/detail.go?type=gene&acc=6223,,,6223.0,RPS19,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of RPS19 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
277,1603989,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6233,RPS27A,https://ctdbase.org/detail.go?type=gene&acc=6233,,,6233.0,RPS27A,9606,Homo sapiens (human),Cannabidiol results in decreased expression of RPS27A mRNA,,,PMID:31801206,https://www.ncbi.nlm.nih.gov/pubmed/31801206,31801206,,
278,1603990,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6188,RPS3,https://ctdbase.org/detail.go?type=gene&acc=6188,,,6188.0,RPS3,9606,Homo sapiens (human),Cannabidiol results in decreased expression of RPS3 protein,,,PMID:34122009,https://www.ncbi.nlm.nih.gov/pubmed/34122009,34122009,,
279,1603991,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of RPS6 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
280,1603992,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,9606,Homo sapiens (human),Cannabidiol results in decreased phosphorylation of RPS6 protein,,,PMID:28392768,https://www.ncbi.nlm.nih.gov/pubmed/28392768,28392768,,
281,1601265,656846,Drug Gene Interaction database (DGIdb),Atorvastatin calcium trihydrate,,ATORVASTATIN CALCIUM TRIHYDRATE,https://www.dgidb.org/drugs/rxcui:1297766,,TNF,https://www.dgidb.org/genes/hgnc:11892,,,7124.0,TNF,9606,Homo sapiens (human),,,,,,,,
282,1602318,667468,Toxin and Toxin Target Database (T3DB),Cidoxepin,T3D2993,Doxepin,http://www.t3db.ca/toxins/T3D2993,BE0000090,Potassium voltage-gated channel subfamily H member 2,http://www.t3db.ca/biodb/bio_entities/BE0000090,Q12809,Potassium voltage-gated channel subfamily H member 2,3757.0,KCNH2,9606,Homo sapiens (human),,,,PMID:17560554,https://www.ncbi.nlm.nih.gov/pubmed/17560554,17560554,,
283,1602319,667468,Toxin and Toxin Target Database (T3DB),Cidoxepin,T3D2993,Doxepin,http://www.t3db.ca/toxins/T3D2993,BE0000945,5-hydroxytryptamine receptor 6,http://www.t3db.ca/biodb/bio_entities/BE0000945,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606,Homo sapiens (human),,,,,,,,
284,1602320,667468,Toxin and Toxin Target Database (T3DB),Cidoxepin,T3D2993,Doxepin,http://www.t3db.ca/toxins/T3D2993,BE0000146,Histamine H4 receptor,http://www.t3db.ca/biodb/bio_entities/BE0000146,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606,Homo sapiens (human),,,,,,,,
285,1602790,667490,Comparative Toxicogenomics Database (CTD),Mercaptopurine,D015122,Mercaptopurine,https://ctdbase.org/detail.go?type=chem&acc=D015122,10486,CAP2,https://ctdbase.org/detail.go?type=gene&acc=10486,,,10486.0,CAP2,10116,Rattus norvegicus (Norway rat),Mercaptopurine results in increased expression of CAP2 mRNA,,,PMID:23358152,https://www.ncbi.nlm.nih.gov/pubmed/23358152,23358152,,
286,1602791,667490,Comparative Toxicogenomics Database (CTD),Mercaptopurine,D015122,Mercaptopurine,https://ctdbase.org/detail.go?type=chem&acc=D015122,12351,CAR4,https://ctdbase.org/detail.go?type=gene&acc=12351,,,12351.0,Car4,10116,Rattus norvegicus (Norway rat),Mercaptopurine results in decreased expression of CAR4 mRNA,,,PMID:23358152,https://www.ncbi.nlm.nih.gov/pubmed/23358152,23358152,,
287,1602792,667490,Comparative Toxicogenomics Database (CTD),Mercaptopurine,D015122,Mercaptopurine,https://ctdbase.org/detail.go?type=chem&acc=D015122,55034,MOCOS,https://ctdbase.org/detail.go?type=gene&acc=55034,,,55034.0,MOCOS,9606,Homo sapiens (human),[MOCOS gene SNP results in decreased oxidation of mercaptopurine] which results in decreased chemical synthesis of 6-thioxanthine|[mocos gene SNP results in decreased oxidation of mercaptopurine] which results in decreased chemical synthesis of 6-thiouric acid|[mocos gene SNP results in decreased oxidation of mercaptopurine] which results in increased chemical synthesis of thioguanine|mocos gene SNP results in decreased oxidation of mercaptopurine,,,PMID:29935280,https://www.ncbi.nlm.nih.gov/pubmed/29935280,29935280,,
288,1602793,667490,Comparative Toxicogenomics Database (CTD),Mercaptopurine,D015122,Mercaptopurine,https://ctdbase.org/detail.go?type=chem&acc=D015122,4488,MSX2,https://ctdbase.org/detail.go?type=gene&acc=4488,,,4488.0,MSX2,10116,Rattus norvegicus (Norway rat),Mercaptopurine results in decreased expression of MSX2 mRNA,,,PMID:23358152,https://www.ncbi.nlm.nih.gov/pubmed/23358152,23358152,,
289,1602794,667490,Comparative Toxicogenomics Database (CTD),Mercaptopurine,D015122,Mercaptopurine,https://ctdbase.org/detail.go?type=chem&acc=D015122,4502,MT2A,https://ctdbase.org/detail.go?type=gene&acc=4502,,,4502.0,MT2A,10116,Rattus norvegicus (Norway rat),Mercaptopurine results in increased expression of MT2A mRNA,,,PMID:23358152,https://www.ncbi.nlm.nih.gov/pubmed/23358152,23358152,,
290,1602795,667490,Comparative Toxicogenomics Database (CTD),Mercaptopurine,D015122,Mercaptopurine,https://ctdbase.org/detail.go?type=chem&acc=D015122,4504,MT3,https://ctdbase.org/detail.go?type=gene&acc=4504,,,4504.0,MT3,10116,Rattus norvegicus (Norway rat),Mercaptopurine results in increased expression of MT3 mRNA,,,PMID:23358152,https://www.ncbi.nlm.nih.gov/pubmed/23358152,23358152,,
291,1603527,667490,Comparative Toxicogenomics Database (CTD),Mercaptopurine,D015122,Mercaptopurine,https://ctdbase.org/detail.go?type=chem&acc=D015122,55273,TMEM100,https://ctdbase.org/detail.go?type=gene&acc=55273,,,55273.0,TMEM100,10116,Rattus norvegicus (Norway rat),Mercaptopurine results in decreased expression of TMEM100 mRNA,,,PMID:23358152,https://www.ncbi.nlm.nih.gov/pubmed/23358152,23358152,,
292,1604100,673609,Drug Gene Interaction database (DGIdb),1-Benzyl-4-(4-ethoxybenzoyl)piperazine,,CHEMBL:CHEMBL585265,https://www.dgidb.org/drugs/chembl:CHEMBL585265,,PKM,https://www.dgidb.org/genes/hgnc:9021,,,5315.0,PKM,9606,Homo sapiens (human),,,,,,,,
293,1604099,673681,Drug Gene Interaction database (DGIdb),2-Mercaptonicotinic acid,,2-MERCAPTONICOTINIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL1521174,,BAZ2B,https://www.dgidb.org/genes/hgnc:963,,,29994.0,BAZ2B,9606,Homo sapiens (human),,,,,,,,
294,1604101,676159,Therapeutic Target Database (TTD),1-Methyl-L-tryptophan,D06YFT,1-methyl-L-tryptophan,https://idrblab.net/ttd/data/drug/details/D06YFT,T89697,"Indoleamine 2,3-dioxygenase 1 (IDO1)",https://idrblab.net/ttd/data/target/details/T89697,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606,Homo sapiens (human),Inhibitor,,,,,,,
295,1604102,676166,Comparative Toxicogenomics Database (CTD),Thioinosine,D013868,Thioinosine,https://ctdbase.org/detail.go?type=chem&acc=D013868,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Thioinosine affects the activity of TP53 protein,,,PMID:35435491,https://www.ncbi.nlm.nih.gov/pubmed/35435491,35435491,,
296,1604103,676290,Drug Gene Interaction database (DGIdb),"2-(2,4-Dihydroxyphenyl)chromen-4-one",,CHEMBL:CHEMBL1374610,https://www.dgidb.org/drugs/chembl:CHEMBL1374610,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606,Homo sapiens (human),,,,,,,,
297,1604104,676296,Drug Gene Interaction database (DGIdb),3-Hydroxy-3'-methoxyflavone,,CHEMBL:CHEMBL272005,https://www.dgidb.org/drugs/chembl:CHEMBL272005,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606,Homo sapiens (human),,,,,,,,
298,1604105,676296,Drug Gene Interaction database (DGIdb),3-Hydroxy-3'-methoxyflavone,,CHEMBL:CHEMBL272005,https://www.dgidb.org/drugs/chembl:CHEMBL272005,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606,Homo sapiens (human),,,,,,,,
299,1604106,676309,Drug Gene Interaction database (DGIdb),"7,8,2'-Trihydroxyflavone",,CHEMBL:CHEMBL244707,https://www.dgidb.org/drugs/chembl:CHEMBL244707,,KDM4E,https://www.dgidb.org/genes/hgnc:37098,,,390245.0,KDM4E,9606,Homo sapiens (human),,,,,,,,
300,1600752,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,2065,ERBB3,https://ctdbase.org/detail.go?type=gene&acc=2065,,,2065.0,ERBB3,9606,Homo sapiens (human),"[dichlorodiphenyldichloroethane co-treated with dichlorodiphenyl dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with aldrin co-treated with dieldrin] results in increased expression of ERBB3 mRNA",,,PMID:19422813,https://www.ncbi.nlm.nih.gov/pubmed/19422813,19422813,,
301,1600753,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,55914,ERBIN,https://ctdbase.org/detail.go?type=gene&acc=55914,,,55914.0,ERBIN,7955,Danio rerio (zebrafish),Dieldrin results in decreased expression of ERBIN mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
302,1600754,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,26059,ERC2,https://ctdbase.org/detail.go?type=gene&acc=26059,,,26059.0,ERC2,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of ERC2 mRNA,,,PMID:20438755,https://www.ncbi.nlm.nih.gov/pubmed/20438755,20438755,,
303,1600755,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,2077,ERF,https://ctdbase.org/detail.go?type=gene&acc=2077,,,2077.0,ERF,10116,Rattus norvegicus (Norway rat),Dieldrin affects the expression of ERF mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
304,1600756,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,157570,ESCO2,https://ctdbase.org/detail.go?type=gene&acc=157570,,,157570.0,ESCO2,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of ESCO2 mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
305,1601563,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,23017,FAIM2,https://ctdbase.org/detail.go?type=gene&acc=23017,,,23017.0,FAIM2,10116,Rattus norvegicus (Norway rat),Dieldrin affects the expression of FAIM2 mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
306,1601564,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,494057,FAM113,https://ctdbase.org/detail.go?type=gene&acc=494057,,,494057.0,fam113,7955,Danio rerio (zebrafish),Dieldrin results in decreased expression of FAM113 mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
307,1601565,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,8603,FAM193A,https://ctdbase.org/detail.go?type=gene&acc=8603,,,8603.0,FAM193A,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of FAM193A mRNA,,,PMID:20438755,https://www.ncbi.nlm.nih.gov/pubmed/20438755,20438755,,
308,1601566,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,57613,FAM234B,https://ctdbase.org/detail.go?type=gene&acc=57613,,,57613.0,FAM234B,7955,Danio rerio (zebrafish),Dieldrin results in increased expression of FAM234B mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
309,1601567,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,378872,FAM49A,https://ctdbase.org/detail.go?type=gene&acc=378872,,,378872.0,fam49a,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of FAM49A mRNA,,,PMID:20438755,https://www.ncbi.nlm.nih.gov/pubmed/20438755,20438755,,
310,1601568,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,9679,FAM53B,https://ctdbase.org/detail.go?type=gene&acc=9679,,,9679.0,FAM53B,7955,Danio rerio (zebrafish),Dieldrin results in increased expression of FAM53B mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
311,1601569,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,51439,FAM8A1,https://ctdbase.org/detail.go?type=gene&acc=51439,,,51439.0,FAM8A1,7955,Danio rerio (zebrafish),Dieldrin results in increased expression of FAM8A1 mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
312,1601570,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,2176,FANCC,https://ctdbase.org/detail.go?type=gene&acc=2176,,,2176.0,FANCC,27706,Micropterus salmoides (largemouth bass),Dieldrin results in decreased expression of FANCC mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
313,1603438,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,2671,GFER,https://ctdbase.org/detail.go?type=gene&acc=2671,,,2671.0,GFER,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of GFER mRNA,,,PMID:20438755,https://www.ncbi.nlm.nih.gov/pubmed/20438755,20438755,,
314,1603439,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,8328,GFI1B,https://ctdbase.org/detail.go?type=gene&acc=8328,,,8328.0,GFI1B,10116,Rattus norvegicus (Norway rat),Dieldrin affects the expression of GFI1B mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
315,1603440,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,2674,GFRA1,https://ctdbase.org/detail.go?type=gene&acc=2674,,,2674.0,GFRA1,9606,Homo sapiens (human),[hexachlorocyclohexane co-treated with aldrin co-treated with dieldrin co-treated with endrin co-treated with dichlorodiphenyl dichloroethylene co-treated with dichlorodiphenyldichloroethane co-treated with DDT co-treated with simvastatin] results in decreased expression of GFRA1 mRNA,,,PMID:28263720,https://www.ncbi.nlm.nih.gov/pubmed/28263720,28263720,,
316,1603441,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,79893,GGNBP2,https://ctdbase.org/detail.go?type=gene&acc=79893,,,79893.0,GGNBP2,27706,Micropterus salmoides (largemouth bass),Estradiol inhibits the reaction [dieldrin results in increased expression of GGNBP2 mrna]|dieldrin results in increased expression of GGNBP2 mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
317,1603442,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,9453,GGPS1,https://ctdbase.org/detail.go?type=gene&acc=9453,,,9453.0,GGPS1,7955,Danio rerio (zebrafish),Dieldrin results in decreased expression of GGPS1 mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
318,1603443,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,2688,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688.0,GH1,27706,Micropterus salmoides (largemouth bass),Estradiol affects the reaction [dieldrin results in decreased expression of GH1 mrna]|dieldrin results in decreased expression of GH1 mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
319,1604403,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,3015,H2AZ1,https://ctdbase.org/detail.go?type=gene&acc=3015,,,3015.0,H2AZ1,10116,Rattus norvegicus (Norway rat),Dieldrin results in increased expression of H2AZ1 mRNA,,,PMID:23153324,https://www.ncbi.nlm.nih.gov/pubmed/23153324,23153324,,
320,1604404,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,145864,HAPLN3,https://ctdbase.org/detail.go?type=gene&acc=145864,,,145864.0,HAPLN3,7955,Danio rerio (zebrafish),Dieldrin results in decreased expression of HAPLN3 mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
321,1604405,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,283254,HARBI1,https://ctdbase.org/detail.go?type=gene&acc=283254,,,283254.0,HARBI1,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of HARBI1 mRNA,,,PMID:20438755,https://www.ncbi.nlm.nih.gov/pubmed/20438755,20438755,,
322,1604406,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,115106,HAUS1,https://ctdbase.org/detail.go?type=gene&acc=115106,,,115106.0,HAUS1,10116,Rattus norvegicus (Norway rat),Dieldrin affects the expression of HAUS1 mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
323,1604407,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,93323,HAUS8,https://ctdbase.org/detail.go?type=gene&acc=93323,,,93323.0,HAUS8,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of HAUS8 mRNA,,,PMID:20438755,https://www.ncbi.nlm.nih.gov/pubmed/20438755,20438755,,
324,1604408,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,3039,HBA1,https://ctdbase.org/detail.go?type=gene&acc=3039,,,3039.0,HBA1,27706,Micropterus salmoides (largemouth bass),Dieldrin results in decreased expression of HBA1 protein,,,PMID:20584760,https://www.ncbi.nlm.nih.gov/pubmed/20584760,20584760,,
325,1604409,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,3040,HBA2,https://ctdbase.org/detail.go?type=gene&acc=3040,,,3040.0,HBA2,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of HBA2 protein,,,PMID:20584760,https://www.ncbi.nlm.nih.gov/pubmed/20584760,20584760,,
326,1604410,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,3050,HBZ,https://ctdbase.org/detail.go?type=gene&acc=3050,,,3050.0,HBZ,7955,Danio rerio (zebrafish),Dieldrin results in increased expression of HBZ mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
327,1604580,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,84717,HDGFL2,https://ctdbase.org/detail.go?type=gene&acc=84717,,,84717.0,HDGFL2,7955,Danio rerio (zebrafish),Dieldrin results in decreased expression of HDGFL2 mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
328,1604581,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,27440,HDHD5,https://ctdbase.org/detail.go?type=gene&acc=27440,,,27440.0,HDHD5,27706,Micropterus salmoides (largemouth bass),Dieldrin results in decreased expression of HDHD5 mRNA,,,PMID:20584760,https://www.ncbi.nlm.nih.gov/pubmed/20584760,20584760,,
329,1604582,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,63897,HEATR6,https://ctdbase.org/detail.go?type=gene&acc=63897,,,63897.0,HEATR6,7955,Danio rerio (zebrafish),Dieldrin results in increased expression of HEATR6 mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
330,1604583,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,3070,HELLS,https://ctdbase.org/detail.go?type=gene&acc=3070,,,3070.0,HELLS,7955,Danio rerio (zebrafish),Dieldrin results in decreased expression of HELLS mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
331,1604584,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,30288,HER6,https://ctdbase.org/detail.go?type=gene&acc=30288,,,30288.0,her6,7955,Danio rerio (zebrafish),Dieldrin results in decreased expression of HER6 mRNA,,,PMID:28385952,https://www.ncbi.nlm.nih.gov/pubmed/28385952,28385952,,
332,1604585,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,8924,HERC2,https://ctdbase.org/detail.go?type=gene&acc=8924,,,8924.0,HERC2,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of HERC2 mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
333,1604586,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,64224,HERPUD2,https://ctdbase.org/detail.go?type=gene&acc=64224,,,64224.0,HERPUD2,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of HERPUD2 mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
334,1604587,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,11112,HIBADH,https://ctdbase.org/detail.go?type=gene&acc=11112,,,11112.0,HIBADH,10116,Rattus norvegicus (Norway rat),Dieldrin results in decreased expression of HIBADH mRNA,,,PMID:23153324,https://www.ncbi.nlm.nih.gov/pubmed/23153324,23153324,,
335,1604588,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,394135,HIBADHB,https://ctdbase.org/detail.go?type=gene&acc=394135,,,394135.0,hibadhb,27706,Micropterus salmoides (largemouth bass),Dieldrin results in decreased expression of HIBADHB mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
336,1600293,2724385,Comparative Toxicogenomics Database (CTD),Digoxin,D004077,Digoxin,https://ctdbase.org/detail.go?type=chem&acc=D004077,6581,SLC22A3,https://ctdbase.org/detail.go?type=gene&acc=6581,,,6581.0,SLC22A3,9606,Homo sapiens (human),Digoxin inhibits the reaction [SLC22A3 protein results in increased uptake of 1-methyl-4-phenylpyridinium],,,PMID:21641380,https://www.ncbi.nlm.nih.gov/pubmed/21641380,21641380,,
337,1601752,2733785,Toxin and Toxin Target Database (T3DB),Indoxyl glucuronide,T3D4200,Inodxyl glucuronide,http://www.t3db.ca/toxins/T3D4200,BE0003645,Solute carrier family 22 member 8,http://www.t3db.ca/biodb/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
338,1601753,2737722,BindingDB,N-[2-(1H-indol-3-yl)ethyl]-4-methylbenzenesulfonamide,22268,N-[2-(1H-indol-3-yl)ethyl]-4-methylbenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22268,2258,Polyunsaturated fatty acid lipoxygenase ALOX15,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2258,P12530,Polyunsaturated fatty acid lipoxygenase ALOX15,100009114.0,ALOX15,9986,Oryctolagus cuniculus (rabbit),,IC50 (nM),>10000,PMID:15713402|DOI:10.1016/j.bmcl.2004.12.081,https://www.ncbi.nlm.nih.gov/pubmed/15713402|https://doi.org/10.1016/j.bmcl.2004.12.081,15713402,10.1016/j.bmcl.2004.12.081,
339,1600532,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,2828,GPR4,https://ctdbase.org/detail.go?type=gene&acc=2828,,,2828.0,GPR4,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in increased expression of GPR4 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
340,1600533,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,8477,GPR65,https://ctdbase.org/detail.go?type=gene&acc=8477,,,8477.0,GPR65,10116,Rattus norvegicus (Norway rat),SCH 23390 results in increased expression of GPR65 mrna|[methamphetamine co-treated with SCH 23390] results in increased expression of GPR65 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
341,1600534,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,223927,GTSF2,https://ctdbase.org/detail.go?type=gene&acc=223927,,,223927.0,Gtsf2,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in decreased expression of GTSF2 mrna|sch 23390 results in decreased expression of GTSF2 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
342,1600535,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,3060,HCRT,https://ctdbase.org/detail.go?type=gene&acc=3060,,,3060.0,HCRT,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in decreased expression of HCRT mrna|sch 23390 results in decreased expression of HCRT mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
343,1600536,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,10116,Rattus norvegicus (Norway rat),SCH 23390 inhibits the reaction [methamphetamine results in increased expression of HERPUD1 mrna]|[methamphetamine co-treated with SCH 23390] results in increased expression of HERPUD1 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
344,1601476,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4665,NAB2,https://ctdbase.org/detail.go?type=gene&acc=4665,,,4665.0,NAB2,10116,Rattus norvegicus (Norway rat),SCH 23390 results in increased expression of NAB2 mrna|[methamphetamine co-treated with SCH 23390] results in increased expression of NAB2 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
345,1601477,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,9348,NDST3,https://ctdbase.org/detail.go?type=gene&acc=9348,,,9348.0,NDST3,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in decreased expression of NDST3 mrna|sch 23390 results in decreased expression of NDST3 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
346,1601478,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,140825,NEURL2,https://ctdbase.org/detail.go?type=gene&acc=140825,,,140825.0,NEURL2,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in decreased expression of NEURL2 mrna|sch 23390 results in decreased expression of NEURL2 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
347,1601479,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4775,NFATC3,https://ctdbase.org/detail.go?type=gene&acc=4775,,,4775.0,NFATC3,10116,Rattus norvegicus (Norway rat),SCH 23390 affects the expression of NFATC3 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
348,1601480,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4775,NFATC3,https://ctdbase.org/detail.go?type=gene&acc=4775,,,4775.0,NFATC3,10116,Rattus norvegicus (Norway rat),SCH 23390 inhibits the reaction [methamphetamine affects the localization of NFATC3 protein],,,PMID:15644446,https://www.ncbi.nlm.nih.gov/pubmed/15644446,15644446,,
349,1601481,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4776,NFATC4,https://ctdbase.org/detail.go?type=gene&acc=4776,,,4776.0,NFATC4,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in decreased expression of NFATC4 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
350,1601482,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4776,NFATC4,https://ctdbase.org/detail.go?type=gene&acc=4776,,,4776.0,NFATC4,10116,Rattus norvegicus (Norway rat),SCH 23390 inhibits the reaction [methamphetamine affects the localization of NFATC4 protein],,,PMID:15644446,https://www.ncbi.nlm.nih.gov/pubmed/15644446,15644446,,
351,1601483,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),SCH 23390 inhibits the reaction [methamphetamine results in increased expression of NFE2L2 mrna]|sch 23390 inhibits the reaction [methamphetamine affects the localization of NFE2L2 protein],,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
352,1601484,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in increased expression of NFIL3 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
353,1601657,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10116,Rattus norvegicus (Norway rat),SCH 23390 inhibits the reaction [cocaine results in increased activity of NFKBIA protein],,,PMID:19183502,https://www.ncbi.nlm.nih.gov/pubmed/19183502,19183502,,
354,1601658,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,137814,NKX2-6,https://ctdbase.org/detail.go?type=gene&acc=137814,,,137814.0,NKX2-6,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] affects the expression of NKX2-6 mrna|sch 23390 affects the expression of NKX2-6 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
355,1601659,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,84504,NKX6-2,https://ctdbase.org/detail.go?type=gene&acc=84504,,,84504.0,NKX6-2,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in decreased expression of NKX6-2 mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
356,1601660,3036864,Comparative Toxicogenomics Database (CTD),"(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol",C534628,SCH 23390,https://ctdbase.org/detail.go?type=chem&acc=C534628,147111,NOTUM,https://ctdbase.org/detail.go?type=gene&acc=147111,,,147111.0,NOTUM,10116,Rattus norvegicus (Norway rat),[methamphetamine co-treated with SCH 23390] results in decreased expression of NOTUM mRNA,,,PMID:19564919,https://www.ncbi.nlm.nih.gov/pubmed/19564919,19564919,,
357,1604335,3245435,Drug Gene Interaction database (DGIdb),"N-cyclohexyl-5,6,7,8-tetrahydro-4H-cyclohepta[d]isoxazole-3-carboxamide",,CHEMBL:CHEMBL600103,https://www.dgidb.org/drugs/chembl:CHEMBL600103,,ATAD5,https://www.dgidb.org/genes/hgnc:25752,,,79915.0,ATAD5,9606,Homo sapiens (human),,,,,,,,
358,1604336,3272524,Therapeutic Target Database (TTD),"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",D02VKC,NBQX,https://idrblab.net/ttd/data/drug/details/D02VKC,T62276,Glutamate receptor ionotropic NMDA 1 (NMDAR1),https://idrblab.net/ttd/data/target/details/T62276,Q05586,"Glutamate receptor ionotropic, NMDA 1",2902.0,GRIN1,9606,Homo sapiens (human),Inhibitor,,,,,,,
359,1604337,3272524,Therapeutic Target Database (TTD),"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",D02VKC,NBQX,https://idrblab.net/ttd/data/drug/details/D02VKC,T73495,Glutamate receptor ionotropic kainate 1 (GRIK1),https://idrblab.net/ttd/data/target/details/T73495,P39086,"Glutamate receptor ionotropic, kainate 1",2897.0,GRIK1,9606,Homo sapiens (human),Inhibitor,,,,,,,
360,1997146,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,10390,CEPT1,https://ctdbase.org/detail.go?type=gene&acc=10390,,,10390.0,CEPT1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CEPT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
361,1997147,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,29956,CERS2,https://ctdbase.org/detail.go?type=gene&acc=29956,,,29956.0,CERS2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CERS2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
362,1997148,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,253782,CERS6,https://ctdbase.org/detail.go?type=gene&acc=253782,,,253782.0,CERS6,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CERS6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
363,1999376,20549618,Therapeutic Target Database (TTD),"2,3-Dihydro-1,4-dithiin-1,1,4,4-tetroxide",D0XR0L,"2,3-dihydro-1,4-dithiin-1,1,4,4-tetroxide",https://idrblab.net/ttd/data/drug/details/D0XR0L,T98494,Galanin receptor (GAL-R),https://idrblab.net/ttd/data/target/details/T98494,O43603,Galanin receptor type 2,8811.0,GALR2,9606,Homo sapiens (human),Antagonist,,,,,,,
364,1999377,20549618,Therapeutic Target Database (TTD),"2,3-Dihydro-1,4-dithiin-1,1,4,4-tetroxide",D0XR0L,"2,3-dihydro-1,4-dithiin-1,1,4,4-tetroxide",https://idrblab.net/ttd/data/drug/details/D0XR0L,T98494,Galanin receptor (GAL-R),https://idrblab.net/ttd/data/target/details/T98494,O60755,Galanin receptor type 3,8484.0,GALR3,9606,Homo sapiens (human),Antagonist,,,,,,,
365,1999375,20924415,BindingDB,"3-[2-(2-Methylpropyl)-1-oxo-1,2-dihydroisoquinolin-4-YL]-1-[2-(morpholin-4-YL)ethyl]urea",496441,MAT-POS-b5746674-109,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496441,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),99000,,,,,
